Terazosin treatment did not enhance glucose intolerance and insulin resistance in GPR119−/− mice (Figure 7C, D), lower fasting blood glucose and serum insulin levels (Figure 7E, F), or alleviate weight loss (Figure 7G). Here, GPR119 is linked to Glucose intolerance.